| Dr Jeffrey L Prebluda, MD | |
|
111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108-3212 | |
| (860) 282-4137 | |
| (860) 282-0170 |
| Full Name | Dr Jeffrey L Prebluda |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 46 Years |
| Location | 111 Founders Plz, East Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699754374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 024617 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massachusetts General Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
News Archive
The European Society of Cardiology (ESC) welcomes an "intriguing" study, published today in the Journal of the American College of Cardiology, featuring a completely novel approach for improving endothelial function in heart failure.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).
URAC, a leading health care accreditation and education organization, announces the release of its Patient Centered Health Care Home Program Toolkit. This new program provides an educational, step-wise, self-paced approach to guide health care practices, and sponsoring health plans, insurers, and pilot programs, on how practices can transform themselves into a patient centered health care home.
› Verified 7 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
The European Society of Cardiology (ESC) welcomes an "intriguing" study, published today in the Journal of the American College of Cardiology, featuring a completely novel approach for improving endothelial function in heart failure.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).
URAC, a leading health care accreditation and education organization, announces the release of its Patient Centered Health Care Home Program Toolkit. This new program provides an educational, step-wise, self-paced approach to guide health care practices, and sponsoring health plans, insurers, and pilot programs, on how practices can transform themselves into a patient centered health care home.
› Verified 7 days ago
| Entity Name | Martha's Vineyard Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194866210 PECOS PAC ID: 9931166113 Enrollment ID: O20041220000589 |
News Archive
The European Society of Cardiology (ESC) welcomes an "intriguing" study, published today in the Journal of the American College of Cardiology, featuring a completely novel approach for improving endothelial function in heart failure.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).
URAC, a leading health care accreditation and education organization, announces the release of its Patient Centered Health Care Home Program Toolkit. This new program provides an educational, step-wise, self-paced approach to guide health care practices, and sponsoring health plans, insurers, and pilot programs, on how practices can transform themselves into a patient centered health care home.
› Verified 7 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
The European Society of Cardiology (ESC) welcomes an "intriguing" study, published today in the Journal of the American College of Cardiology, featuring a completely novel approach for improving endothelial function in heart failure.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).
URAC, a leading health care accreditation and education organization, announces the release of its Patient Centered Health Care Home Program Toolkit. This new program provides an educational, step-wise, self-paced approach to guide health care practices, and sponsoring health plans, insurers, and pilot programs, on how practices can transform themselves into a patient centered health care home.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey L Prebluda, MD 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108-3212 Ph: (860) 282-4137 | Dr Jeffrey L Prebluda, MD 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108-3212 Ph: (860) 282-4137 |
News Archive
The European Society of Cardiology (ESC) welcomes an "intriguing" study, published today in the Journal of the American College of Cardiology, featuring a completely novel approach for improving endothelial function in heart failure.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).
URAC, a leading health care accreditation and education organization, announces the release of its Patient Centered Health Care Home Program Toolkit. This new program provides an educational, step-wise, self-paced approach to guide health care practices, and sponsoring health plans, insurers, and pilot programs, on how practices can transform themselves into a patient centered health care home.
› Verified 7 days ago
Dr. Sung-chil Hong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Dr. Marc Andre Paradis, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Dr. Alexander S. Peck Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Dr. Peter H Diamond, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 99 E River Dr, 5th Floor, East Hartford, CT 06108 Phone: 860-282-4022 Fax: 860-289-0746 | |
Dr. Leslie S Kish, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Nancy J Weinstein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Founders Plz, #300, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Dr. Michael Anthony Miranda Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 |